Thyroid diseases and cerebrovascular disease

被引:202
作者
Squizzato, A
Gerdes, VEA
Brandjes, DPM
Büller, HR
Stam, J
机构
[1] Univ Insubria, Dept Internal Med, I-21100 Varese, Italy
[2] Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, NL-1105 AZ Amsterdam, Netherlands
[3] Slotervaart Hosp, Dept Internal Med, Amsterdam, Netherlands
[4] Univ Amsterdam, Acad Med Ctr, Dept Neurol, NL-1105 AZ Amsterdam, Netherlands
关键词
arteriosclerosis; cerebrovascular disorders; hyperthyroidism; hypothyroidism; thrombophilia;
D O I
10.1161/01.STR.0000181772.78492.07
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background and Purpose-Acute cerebral ischemia has been described in different diseases of the thyroid gland, and not only as a result of thyrotoxic atrial fibrillation and cardioembolic stroke. The purpose of this review is to summarize the studies on the relationship between thyroid diseases and cerebrovascular diseases, discussing the main findings for overt hyperthyroidism and hypothyroidism, as well as for subclinical thyroid dysfunction. Summary of Review-In overt hyperthyroidism, cardioembolic stroke is clearly associated to thyrotoxic atrial fibrillation, and in subclinical hyperthyroidism with serum thyroid-stimulating hormone levels <0.1 mU/L, the incidence of atrial fibrillation is increased. Although in vitro and in vivo studies indicate a hypercoagulability state in hyperthyroidism, there is insufficient evidence to prove that this state leads to an increased risk of cardiac emboli. However, the hypothesis that overt hyperthyroidism may cause acute cerebral venous thrombosis is intriguing. Possible associations between hyperthyroidism and Moyamoya or Giant cell arteritis have only been described in case reports. There is enough evidence that overt hypothyroidism is associated with several traditional and newer atherosclerotic risk factors, especially hypertension, hyperlipidemia, and hyperhomocysteinemia. For subclinical hypothyroidism, these associations are less certain. Hypothyroidism has been associated with signs of aortic or coronary atherosclerosis, but no case-control or cohort studies have ever investigated hypothyroidism as a possible risk factor for atherothrombotic stroke. Conclusions-Hyperthyroidism is associated with atrial fibrillation and cardioembolic stroke. Hypothyroidism is associated with a worse cardiovascular risk factor profile and leads to progression of atherosclerosis. Associations between hyperthyroidism and acute cerebral venous thrombosis, Moyamoya, and Giant cell arteritis have been suggested, but sound evidence is lacking. Additional studies are needed to clarify these issues.
引用
收藏
页码:2302 / 2310
页数:9
相关论文
共 130 条
[1]   Thyroid function is associated with presence and severity of coronary atherosclerosis [J].
Auer, J ;
Berent, R ;
Weber, T ;
Lassnig, E ;
Eber, B .
CLINICAL CARDIOLOGY, 2003, 26 (12) :569-573
[2]   Subclinical hyperthyroidism as a risk factor for atrial fibrillation [J].
Auer, J ;
Scheibner, P ;
Mische, T ;
Langsteger, W ;
Eber, O ;
Eber, B .
AMERICAN HEART JOURNAL, 2001, 142 (05) :838-842
[3]   The relationship between thyrotropin and low density lipoprotein cholesterol is modified by insulin sensitivity in healthy euthyroid subjects [J].
Bakker, SJL ;
ter Maaten, JC ;
Popp-Snijders, C ;
Slaets, JPJ ;
Heine, RJ ;
Gans, ROB .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (03) :1206-1211
[4]   Homocysteine, folate, vitamin B12, and transcobalamins in patients undergoing successive hypo- and hyperthyroid states [J].
Barbé, F ;
Klein, M ;
Chango, A ;
Frémont, S ;
Gérard, P ;
Weryha, G ;
Guéant, JL ;
Nicolas, JP .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (04) :1845-1846
[5]   ARTERIAL EMBOLISM IN THYROTOXICOSIS WITH ATRIAL-FIBRILLATION [J].
BARSELA, S ;
EHRENFELD, M ;
ELIAKIM, M .
ARCHIVES OF INTERNAL MEDICINE, 1981, 141 (09) :1191-1192
[6]  
BASTENIE PA, 1967, LANCET, V2, P1221
[7]  
BASTENIE PA, 1971, LANCET, V1, P203
[8]   REVERSIBLE HYPERTENSION AND HYPOTHYROIDISM [J].
BING, RF ;
BRIGGS, RSJ ;
BURDEN, AC ;
RUSSELL, GI ;
SWALES, JD ;
THURSTON, H .
CLINICAL ENDOCRINOLOGY, 1980, 13 (04) :339-342
[9]  
BOWNESS P, 1991, BRIT J RHEUMATOL, V30, P349
[10]  
Bruckert E, 1999, J CARDIOVASC RISK, V6, P327